Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Bullboard Posts
Comment by longterm56on Feb 02, 2019 12:04am
69 Views
Post# 29309228

RE:RE:RE:RE:RE:RE:RE:Timeline???

RE:RE:RE:RE:RE:RE:RE:Timeline???Yea ... that's a more polite way of saying it ;) 

  -LT

PoorOpinion wrote: Congratulations, you've worked out there is a degree of speculation going on here.

longterm56 wrote:
SPCEO1 wrote:
 Because, if the author is correct, the idea that GILD would be interested in acquiring TH would be almost impossible to refute.   
Exactly where does this idea (GILD being interested in acquiring TH) originate?  Oh ... you made it up!  How can I refute a fantasy other thn asking you where it came from?

And how can you substantiate this ...

SPCEO1 wrote:
I am sure they know something about all the companies in the HIV space. I have to think they were involved in bidding for Trogarzo because it is pretty easy to see how Taimed rejected the normal big pharma, royalty route to do a deal with TH where they could maintain more control over Trogarzo. If that is correct, they certainly know who TH is since they lost out to them and probably still can't figure out how that happened.


How can I refute "I am sure they know ..."?

Sorry, but I'm frustrated by all the positive new and negative performance ...

   -LT

 




Bullboard Posts